酸性スフィンゴミエリナーゼ欠損症薬のグローバル市場調査 2019年

• 英文タイトル：Global Acid Sphingomyelinase Deficiency Drug Market Professional Survey Report 2019

• レポートコード：QYR9NV00079
• 出版社/出版日：QYResearch / 2019年11月12日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・ヘルスケア

• 販売価格（消費税別）

Single User	￥525,000 (USD3,500)	▷ お問い合わせ
Enterprise License	￥1,050,000 (USD7,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートは、酸性スフィンゴミエリナーゼ欠損症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、LJPC-0712、ML-SA1、OKL-1014、オリプダーゼアルファ、OR-0005、その他に、用途別には、病院、クリニック、その他にセグメント区分し、酸性スフィンゴミエリナーゼ欠損症薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・酸性スフィンゴミエリナーゼ欠損症薬の世界市場概要
・酸性スフィンゴミエリナーゼ欠損症薬の製造コスト構成分析
・酸性スフィンゴミエリナーゼ欠損症薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・酸性スフィンゴミエリナーゼ欠損症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・酸性スフィンゴミエリナーゼ欠損症薬のセグメント分析（種類別）
（LJPC-0712、ML-SA1、OKL-1014、オリプダーゼアルファ、OR-0005、その他）
・酸性スフィンゴミエリナーゼ欠損症薬のセグメント分析（用途別）
（病院、クリニック、その他）
・酸性スフィンゴミエリナーゼ欠損症薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Genzyme Corporation、La Jolla Pharmaceutical Company、Merck & Co., Inc.、Okklo Life Sciences BV、Orphazyme ApS、）
・酸性スフィンゴミエリナーゼ欠損症薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

The global Acid Sphingomyelinase Deficiency Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Acid Sphingomyelinase Deficiency Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acid Sphingomyelinase Deficiency Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Acid Sphingomyelinase Deficiency Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Acid Sphingomyelinase Deficiency Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Genzyme Corporation
La Jolla Pharmaceutical Company
Merck & Co., Inc.
Okklo Life Sciences BV
Orphazyme ApS
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
LJPC-0712
ML-SA1
OKL-1014
Olipudase Alfa
OR-0005
Others

Segment by Application
Hospital
Clinic
Others

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Acid Sphingomyelinase Deficiency Drug
1.1 Definition of Acid Sphingomyelinase Deficiency Drug
1.2 Acid Sphingomyelinase Deficiency Drug Segment by Type
1.2.1 Global Acid Sphingomyelinase Deficiency Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 LJPC-0712
1.2.3 ML-SA1
1.2.4 OKL-1014
1.2.5 Olipudase Alfa
1.2.6 OR-0005
1.2.7 Others
1.3 Acid Sphingomyelinase Deficiency Drug Segment by Applications
1.3.1 Global Acid Sphingomyelinase Deficiency Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Acid Sphingomyelinase Deficiency Drug Overall Market
1.4.1 Global Acid Sphingomyelinase Deficiency Drug Revenue (2014-2025)
1.4.2 Global Acid Sphingomyelinase Deficiency Drug Production (2014-2025)
1.4.3 North America Acid Sphingomyelinase Deficiency Drug Status and Prospect (2014-2025)
1.4.4 Europe Acid Sphingomyelinase Deficiency Drug Status and Prospect (2014-2025)
1.4.5 China Acid Sphingomyelinase Deficiency Drug Status and Prospect (2014-2025)
1.4.6 Japan Acid Sphingomyelinase Deficiency Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Acid Sphingomyelinase Deficiency Drug Status and Prospect (2014-2025)
1.4.8 India Acid Sphingomyelinase Deficiency Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Acid Sphingomyelinase Deficiency Drug
2.3 Manufacturing Process Analysis of Acid Sphingomyelinase Deficiency Drug
2.4 Industry Chain Structure of Acid Sphingomyelinase Deficiency Drug

3 Development and Manufacturing Plants Analysis of Acid Sphingomyelinase Deficiency Drug
3.1 Capacity and Commercial Production Date
3.2 Global Acid Sphingomyelinase Deficiency Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Acid Sphingomyelinase Deficiency Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Acid Sphingomyelinase Deficiency Drug Production and Capacity Analysis
4.2 Acid Sphingomyelinase Deficiency Drug Revenue Analysis
4.3 Acid Sphingomyelinase Deficiency Drug Price Analysis
4.4 Market Concentration Degree

5 Acid Sphingomyelinase Deficiency Drug Regional Market Analysis
5.1 Acid Sphingomyelinase Deficiency Drug Production by Regions
5.1.1 Global Acid Sphingomyelinase Deficiency Drug Production by Regions
5.1.2 Global Acid Sphingomyelinase Deficiency Drug Revenue by Regions
5.2 Acid Sphingomyelinase Deficiency Drug Consumption by Regions
5.3 North America Acid Sphingomyelinase Deficiency Drug Market Analysis
5.3.1 North America Acid Sphingomyelinase Deficiency Drug Production
5.3.2 North America Acid Sphingomyelinase Deficiency Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Acid Sphingomyelinase Deficiency Drug Import and Export
5.4 Europe Acid Sphingomyelinase Deficiency Drug Market Analysis
5.4.1 Europe Acid Sphingomyelinase Deficiency Drug Production
5.4.2 Europe Acid Sphingomyelinase Deficiency Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Acid Sphingomyelinase Deficiency Drug Import and Export
5.5 China Acid Sphingomyelinase Deficiency Drug Market Analysis
5.5.1 China Acid Sphingomyelinase Deficiency Drug Production
5.5.2 China Acid Sphingomyelinase Deficiency Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Acid Sphingomyelinase Deficiency Drug Import and Export
5.6 Japan Acid Sphingomyelinase Deficiency Drug Market Analysis
5.6.1 Japan Acid Sphingomyelinase Deficiency Drug Production
5.6.2 Japan Acid Sphingomyelinase Deficiency Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Acid Sphingomyelinase Deficiency Drug Import and Export
5.7 Southeast Asia Acid Sphingomyelinase Deficiency Drug Market Analysis
5.7.1 Southeast Asia Acid Sphingomyelinase Deficiency Drug Production
5.7.2 Southeast Asia Acid Sphingomyelinase Deficiency Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Acid Sphingomyelinase Deficiency Drug Import and Export
5.8 India Acid Sphingomyelinase Deficiency Drug Market Analysis
5.8.1 India Acid Sphingomyelinase Deficiency Drug Production
5.8.2 India Acid Sphingomyelinase Deficiency Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Acid Sphingomyelinase Deficiency Drug Import and Export

6 Acid Sphingomyelinase Deficiency Drug Segment Market Analysis (by Type)
6.1 Global Acid Sphingomyelinase Deficiency Drug Production by Type
6.2 Global Acid Sphingomyelinase Deficiency Drug Revenue by Type
6.3 Acid Sphingomyelinase Deficiency Drug Price by Type

7 Acid Sphingomyelinase Deficiency Drug Segment Market Analysis (by Application)
7.1 Global Acid Sphingomyelinase Deficiency Drug Consumption by Application
7.2 Global Acid Sphingomyelinase Deficiency Drug Consumption Market Share by Application (2014-2019)

8 Acid Sphingomyelinase Deficiency Drug Major Manufacturers Analysis
8.1 Genzyme Corporation
8.1.1 Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
8.1.2 Genzyme Corporation Product Introduction, Application and Specification
8.1.3 Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 La Jolla Pharmaceutical Company
8.2.1 La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
8.2.2 La Jolla Pharmaceutical Company Product Introduction, Application and Specification
8.2.3 La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Merck & Co., Inc.
8.3.1 Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
8.3.2 Merck & Co., Inc. Product Introduction, Application and Specification
8.3.3 Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Okklo Life Sciences BV
8.4.1 Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
8.4.2 Okklo Life Sciences BV Product Introduction, Application and Specification
8.4.3 Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Orphazyme ApS
8.5.1 Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
8.5.2 Orphazyme ApS Product Introduction, Application and Specification
8.5.3 Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Acid Sphingomyelinase Deficiency Drug Market
9.1 Global Acid Sphingomyelinase Deficiency Drug Market Trend Analysis
9.1.1 Global Acid Sphingomyelinase Deficiency Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Acid Sphingomyelinase Deficiency Drug Regional Market Trend
9.2.1 North America Acid Sphingomyelinase Deficiency Drug Forecast 2019-2025
9.2.2 Europe Acid Sphingomyelinase Deficiency Drug Forecast 2019-2025
9.2.3 China Acid Sphingomyelinase Deficiency Drug Forecast 2019-2025
9.2.4 Japan Acid Sphingomyelinase Deficiency Drug Forecast 2019-2025
9.2.5 Southeast Asia Acid Sphingomyelinase Deficiency Drug Forecast 2019-2025
9.2.6 India Acid Sphingomyelinase Deficiency Drug Forecast 2019-2025
9.3 Acid Sphingomyelinase Deficiency Drug Market Trend (Product Type)
9.4 Acid Sphingomyelinase Deficiency Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Acid Sphingomyelinase Deficiency Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Acid Sphingomyelinase Deficiency Drug
Table Global Acid Sphingomyelinase Deficiency Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Acid Sphingomyelinase Deficiency Drug Production Market Share by Types in 2018
Figure LJPC-0712 Product Picture
Figure ML-SA1 Product Picture
Figure OKL-1014 Product Picture
Figure Olipudase Alfa Product Picture
Figure OR-0005 Product Picture
Figure Others Product Picture
Table Global Acid Sphingomyelinase Deficiency Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Acid Sphingomyelinase Deficiency Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Acid Sphingomyelinase Deficiency Drug Revenue (Million USD) (2014-2025)
Figure Global Acid Sphingomyelinase Deficiency Drug Production (K Pcs) (2014-2025)
Figure North America Acid Sphingomyelinase Deficiency Drug Market Size (Million USD) (2014-2025)
Figure Europe Acid Sphingomyelinase Deficiency Drug Market Size (Million USD) (2014-2025)
Figure China Acid Sphingomyelinase Deficiency Drug Market Size (Million USD) (2014-2025)
Figure Japan Acid Sphingomyelinase Deficiency Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Acid Sphingomyelinase Deficiency Drug Market Size (Million USD) (2014-2025)
Figure India Acid Sphingomyelinase Deficiency Drug Market Size (Million USD) (2014-2025)
Table Acid Sphingomyelinase Deficiency Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Acid Sphingomyelinase Deficiency Drug in 2018
Figure Manufacturing Process Analysis of Acid Sphingomyelinase Deficiency Drug
Figure Industry Chain Structure of Acid Sphingomyelinase Deficiency Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Acid Sphingomyelinase Deficiency Drug Manufacturing Plants Distribution
Table Acid Sphingomyelinase Deficiency Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Acid Sphingomyelinase Deficiency Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Acid Sphingomyelinase Deficiency Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Acid Sphingomyelinase Deficiency Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Acid Sphingomyelinase Deficiency Drug Production Share by Manufacturers in 2018
Table Acid Sphingomyelinase Deficiency Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Acid Sphingomyelinase Deficiency Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Acid Sphingomyelinase Deficiency Drug Revenue Share by Manufacturers in 2018
Table Acid Sphingomyelinase Deficiency Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Acid Sphingomyelinase Deficiency Drug Production by Regions 2014-2019 (K Pcs)
Table Global Acid Sphingomyelinase Deficiency Drug Production Market Share by Regions 2014-2019
Figure Global Acid Sphingomyelinase Deficiency Drug Production Market Share by Regions in 2018
Table Global Acid Sphingomyelinase Deficiency Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Acid Sphingomyelinase Deficiency Drug Revenue Market Share by Regions 2014-2019
Figure Global Acid Sphingomyelinase Deficiency Drug Revenue Market Share by Regions in 2018
Table Global Acid Sphingomyelinase Deficiency Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Acid Sphingomyelinase Deficiency Drug Consumption Market Share by Regions 2014-2019
Figure North America Acid Sphingomyelinase Deficiency Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Acid Sphingomyelinase Deficiency Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Acid Sphingomyelinase Deficiency Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Acid Sphingomyelinase Deficiency Drug Production, Consumption Import and Export (K Pcs)
Figure China Acid Sphingomyelinase Deficiency Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Acid Sphingomyelinase Deficiency Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Acid Sphingomyelinase Deficiency Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Acid Sphingomyelinase Deficiency Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Acid Sphingomyelinase Deficiency Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Acid Sphingomyelinase Deficiency Drug Production, Consumption Import and Export (K Pcs)
Figure India Acid Sphingomyelinase Deficiency Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Acid Sphingomyelinase Deficiency Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Acid Sphingomyelinase Deficiency Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Acid Sphingomyelinase Deficiency Drug Market Share by Application (2014-2019)
Table Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
Table Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Product Introduction, Application and Specification
Table Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Production Growth Rate (2014-2019)
Table Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Production Market Share (2014-2019)
Figure Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Revenue Market Share (2014-2019)
Table Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Main Business and Markets Served
Table La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
Table La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Product Introduction, Application and Specification
Table La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Production Growth Rate (2014-2019)
Table La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Production Market Share (2014-2019)
Figure La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Revenue Market Share (2014-2019)
Table La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Main Business and Markets Served
Table Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
Table Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Product Introduction, Application and Specification
Table Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Production Growth Rate (2014-2019)
Table Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Production Market Share (2014-2019)
Figure Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Revenue Market Share (2014-2019)
Table Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Main Business and Markets Served
Table Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
Table Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Product Introduction, Application and Specification
Table Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Production Growth Rate (2014-2019)
Table Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Production Market Share (2014-2019)
Figure Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Revenue Market Share (2014-2019)
Table Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Main Business and Markets Served
Table Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
Table Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Product Introduction, Application and Specification
Table Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Production Growth Rate (2014-2019)
Table Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Production Market Share (2014-2019)
Figure Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Revenue Market Share (2014-2019)
Table Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Main Business and Markets Served
Figure Global Acid Sphingomyelinase Deficiency Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Acid Sphingomyelinase Deficiency Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Acid Sphingomyelinase Deficiency Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Acid Sphingomyelinase Deficiency Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Acid Sphingomyelinase Deficiency Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Acid Sphingomyelinase Deficiency Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Acid Sphingomyelinase Deficiency Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Acid Sphingomyelinase Deficiency Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Acid Sphingomyelinase Deficiency Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Acid Sphingomyelinase Deficiency Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Acid Sphingomyelinase Deficiency Drug by Application (2019-2025)
Table Acid Sphingomyelinase Deficiency Drug Distributors List
Table Acid Sphingomyelinase Deficiency Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

エチドロン酸のグローバル市場調査 2019年

Global Etidronic Acid Market Professional Survey Report 2019
QYR9NV04524 2019年11月12日 100Pages
※本調査レポートは、エチドロン酸の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、医薬品グレードエチドロン酸、工業用グレードエチドロン酸に、用途別には、製薬産業...

甲状腺機能低下症薬のグローバル市場調査 2019年

Global Hypothyroidism Drug Market Professional Survey Report 2019
QYR9NV06525 2019年11月12日 109Pages
※本調査レポートは、甲状腺機能低下症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、...

ファンコニ貧血薬のグローバル市場調査 2019年

Global Fanconi Anemia Drug Market Professional Survey Report 2019
QYR9NV04652 2019年11月12日 109Pages
※本調査レポートは、ファンコニ貧血薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エルトロンボパグオラミン、EXG-34217、ファンカレン、その他に、用途...

コクシジオイデス症薬剤のグローバル市場調査 2019年

Global Coccidioidomycosis Drug Market Professional Survey Report 2019
QYR9NV02704 2019年11月12日 105Pages
※本調査レポートは、コクシジオイデス症薬剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VT-1161、APX-001、VT-1598、ニッコマイシンZ、そ...

医療用酒石酸のグローバル市場調査 2019年

Global Medical Tartaric Acid Market Professional Survey Report 2019
QYR9NV08134 2019年11月14日 111Pages
※本調査レポートは、医療用酒石酸の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、有機合成、人工合成に、用途別には、医薬品産業原料、キラル触媒、複雑な天然物分子...

膿痂疹薬のグローバル市場調査 2019年

Global Impetigo Drug Market Professional Survey Report 2019
QYR9NV06572 2019年11月12日 106Pages
※本調査レポートは、膿痂疹薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、FMX-102、LTX-109、ムピロシン、オゼノキサシン、その他に、用途別には、...

緑膿菌肺炎治療薬のグローバル市場調査 2019年

Global Pseudomonas Aeruginosa Pneumonia Drug Market Professional Survey Report 2019
QYR9NV10765 2019年11月14日 107Pages
※本調査レポートは、緑膿菌肺炎治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アエルシン、EV-035、MEDI-3902、パノバクマブ、その他に、用途...

世界及び中国のウルソデオキシコール酸薬市場2018 The 'Global and Chinese Ursodeoxycholic Acid Drug Product Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Ursodeoxycholic Acid Drug Product industry with a focus on the Chinese market. The report provides key statistics on the marke…
世界及び中国の第VIII因子欠乏症治療市場2018 The 'Global and Chinese Factor VIII Deficiency Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Factor VIII Deficiency Treatment industry with a focus on the Chinese market. The report provides key statistics on the market …
ビスホスホネート薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Bisphosphonates are drugs that inhibit mineralization or resorption of the bone by blocking the action of osteoclasts. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of b…
エチドロン酸のグローバル市場調査 2019年 The global Etidronic Acid market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Etidronic Acid volume and value at global level, regional level and company level. From a global perspective, this report re…
世界及び中国のヘキサン酸（カプロン酸）市場2018 The 'Global and Chinese Hexanoic acid (caproic acid) Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Hexanoic acid (caproic acid) industry with a focus on the Chinese market. The report provides key statistics on the market status o…